GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » 5-Year Yield-on-Cost %

InspireMD (FRA:II2) 5-Year Yield-on-Cost % : 0.00 (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is InspireMD 5-Year Yield-on-Cost %?

InspireMD's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for InspireMD's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:II2's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.295
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of InspireMD's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, InspireMD's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where InspireMD's 5-Year Yield-on-Cost % falls into.



InspireMD 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of InspireMD is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

InspireMD  (FRA:II2) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


InspireMD 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of InspireMD's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


InspireMD (FRA:II2) Business Description

Traded in Other Exchanges
Address
4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines